31,116 resources
By Version
By Authority
By Realm
Start Prev Rows 10000 - 10200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
signal.core.r4 | R4 | questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | 1 | pa | us | hl7 | ||
ans.fr.nos | R4 | JDV-J242-ActionAnomalie-ROR | JDV_J242-ActionAnomalie-ROR | active | 2023-03 | fr | national | |||
hl7.terminology | R5 | adverse-event-clinical-research-seriousness-criteria | Adverse Event Clinical Research Seriousness Criteria | active | 1 | brr | 2023-07 | uv | hl7 | ncit |
hl7.terminology.r4b | R4B | adverse-event-clinical-research-seriousness-criteria | Adverse Event Clinical Research Seriousness Criteria | active | 1 | brr | 2023-07 | uv | hl7 | ncit |
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-action-guidance-for-types | Action guidance For Types | active | 2021-10 | dk | fhir | |||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-action-guidance-types | Action guidance types | active | 2021-10 | dk | ||||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | vs-action-selection-behavior-required | Action Selection Behavior Required | draft | 2022-11 | uv | hl7 | fhir | ||
hl7.terminology | R5 | v3-ActAdjudicationResultActionCode | ActAdjudicationResultActionCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology.r4b | R4B | v3-ActAdjudicationResultActionCode | ActAdjudicationResultActionCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.fhir.nl.zorgviewer | R3 | ACPTreatmentCodelist | ACP behandelingen waardelijst | active | 2025-07 | nl | hl7 | sct | ||
MyHIE.v4-test | R4 | value-set-active-ingredient-my-core | ValueSetActiveIngredient (MY Core) | active | 2023-01 | |||||
MyHIE.v4-test | R4 | value-set-allergy-environment-my-core | ValueSetAllergyEnvironment (MY Core) | active | 2023-01 | |||||
IdHIE.0v | R4 | value-set-active-ingredient-id-core | ValueSetActiveIngredient (ID Core) | active | 2023-06 | hl7 | ||||
IdHIE.0v | R4 | value-set-allergy-environment-id-core | ValueSetAllergyEnvironment (ID Core) | active | 2023-06 | hl7 | ||||
hl7.fhir.uv.cpg | R4 | cpg-active-condition-vs | CPG Active Condition Value Set | active | cds | 2024-11 | uv | hl7 | tho | |
fhir.cqf.common | R4 | active-condition | CQF Active Condition | active | 2019-07 | us | hl7 | tho | ||
hl7.eu.fhir.pcsp | R4 | activeResolved-condition-vs | Active or resolved Condition | active | 2023-01 | eu | hl7 | tho | ||
ch.fhir.ig.ch-term | R4 | ActivePharmaceuticalIngredient | ActivePharmaceuticalIngredient | active | 2025-05 | ch | hl7 | sct | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.13.3--20200901000000 | ActiviteitCodelijst | active | nl | hl7 | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.13.3--20171231000000 | ActiviteitCodelijst | active | nl | oid | ||||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-activitydefinition-code | Activity Definition Code | active | 2019-02 | dk | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8014 | Activity Type Anthrax | active | 2020-01 | us | tho oid | |||
hl7.fhir.us.vrdr | R4 | vrdr-activity-at-time-of-death-vs | Activity at Time of Death ValueSet | active | pher | 2024-10 | us | hl7 | fhir tho | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3102 | Skin Exposure Activity (FDD) | active | 2008-01 | us | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) | active | 2020-01 | us | sct tho oid | |||
ans.fr.nos | R4 | JDV-J17-ActiviteOperationnelle-ROR | JDV_J17-ActiviteOperationnelle-ROR | active | 2024-12 | fr | national | |||
ans.fr.nos | R4 | JDV-J94-GenreActivite-RASS | JDV_J94-GenreActivite-RASS | active | 2024-03 | fr | national | |||
ans.fr.terminologies | R4 | JDV-J69-ActiviteOperationnelle-Santefr | JDV J69 ActiviteOperationnelle Santefr | retired | 2024-05 | fr | national | |||
ans.fr.nos | R4 | JDV-J133-ActiviteSanitaireRegulee-RASS | JDV_J133-ActiviteSanitaireRegulee-RASS | active | 2020-11 | fr | national | |||
ch.fhir.ig.ch-epr-fhir | R4 | PpqmActorIdentifierType | CH PPQm Actor Identifier Type | active | 2025-05 | ch | hl7 | ietf | ||
ch.fhir.ig.ch-epr-ppqm | R4 | PpqmActorIdentifierType | PPQm Actor Identifier Type | active | 2023-12 | ch | hl7 | ietf | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) | active | 2020-01 | us | sct tho | |||
hl7.fhir.us.nhsn-dqm | R4 | ach-encounter-class | Acute Care Hospital Encounter Class ValueSet | trial-use | 1 | pher | 2025-07 | us | hl7 | tho |
hl7.fhir.us.nhsn-dqm | R4 | ach-encounter-status | Acute Care Hospital Encounter Status ValueSet | trial-use | 1 | pher | 2025-07 | us | hl7 | fhir |
ca.on.oh.corhealth | R4 | CorHealth45AcuteCoronarySyndromeClassificationVS | Acute Coronary Syndrome Classification | active | ||||||
hl7.eu.fhir.pcsp | R4 | vs-Gvhd-acute-grade-eu-pcsp | Acute Gvhd Grade | active | 2023-01 | eu | hl7 | internal tho | ||
hl7.eu.fhir.pcsp | R4 | vs-Gvhd-chronic-grade-eu-pcsp | Chronic Gvhd condition | active | 2023-01 | eu | hl7 | internal tho | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) | active | 2009-01 | us | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3206 | Lab Test Result Name (Acute Hepatitis B) | active | 2009-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) | active | 2009-01 | us | sct | |||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.10416 | Financially Responsible Party Type Value Set | active | 2024-06 | us | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.20 | Telecom Use (US Realm Header) | active | 2024-06 | us | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.19579 | Family Member Value | active | 2024-06 | us | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.38 | Smoking Status | active | 2024-06 | us | hl7 | sct | ||
robin.gittest | R4 | be-vs-addiction-category | Addiction Category | draft | 2021-01 | |||||
robin.gittest | R4 | be-vs-addiction-code | Addiction Code | draft | 2021-01 | |||||
hl7.fhir.uv.tools | R5 | additional-binding-purpose | Additional Binding Purpose ValueSet | informative | 4 | fhir | 2025-07 | uv | hl7 | fhir |
ca.on.ehr.r4 | R4 | additional-binding-purpose | Additional Binding Purpose ValueSet | active | uv | national | fhir | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3162 | Risk Factors (TB) | active | 2008-01 | us | sct tho oid | |||
ch.fhir.ig.ch-term | R4 | condition-category | Condition Category Codes | active | 2025-05 | ch | hl7 | |||
gov.healthit.ecqi.ecqms.subset | R4 | extended-usage-context-type | Extended Usage Context Type | active | 2025-06 | tho | ||||
hl7.fhir.uv.cardx-cied | R5 | cied-connectivity-state-modifier-vs | CIED Connectivity Status Modifier Value Set | trial-use | 2 | cic | 2025-07 | uv | hl7 | fhir |
tewhatuora.hip-core | R4 | nhi-name-use-extra-1.0 | NHI Name Use Extra | active | 2022-04 | national | ||||
healthdata.be.r4.cbb | R4 | AdditionalWishes | AdditionalWishes | draft | oid | |||||
ForgePatientChart.0830 | R4 | telus-address-state | TELUS ValueSet - Address State | draft | 2020-11 | hl7 | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.801 | Address Type (HL7) | active | 2018-01 | us | tho | |||
hl7.fhir.us.davinci-crd | R4 | locationAddressType | CRD Location Address Types Value Set | trial-use | 3 | fm | 2025-07 | us | hl7 | fhir |
ee.fhir.terminology | R5 | ads-adr-id | ADS AdrId | active | 2025-06 | ee | hl7 | internal | ||
ee.fhir.terminology | R5 | ads-oid | ADS Oid | active | 2025-06 | ee | hl7 | internal | ||
hl7.fhir.us.davinci-hrex | R4 | hrex-coverage-relationship | HRex Coverage Relationship ValueSet | draft | 0 | cic | 2025-04 | us | hl7 | fhir tho |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping | active | 2024-03 | us | hl7 | vsac | ||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.285--20200616133418 | Ademhaling | active | nl | fhir sct | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20200901000000 | AdemhalingScoreCodelijst | active | nl | hl7 | loinc | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20171231000000 | AdemhalingScoreCodelijst | active | nl | loinc | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.3--20200901000000 | AdemhalingsreactieCodelijst | active | nl | hl7 | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.3--20171231000000 | AdemhalingsreactieCodelijst | active | nl | oid | ||||
hl7.fhir.uv.emedicinal-product-info | R5 | administrableDoseForm | Administrable Pharmaceutical Dose Form | active | 2025-07 | uv | hl7 | fhir | ||
ans.fr.terminologies | R4 | jdv-hl7-v3-AdministrableDrugForm-cisis | AdministrableDrugForm | active | 2025-06 | fr | national | tho | ||
dk.kip.rkkp.fhir.ig.core | R4 | AdministrationTypeDCCG | Administrationstype Jern (DCCG) | active | 2022-11 | internal | ||||
hl7.terminology | R5 | v3-AdministrationDetectedIssueCode | AdministrationDetectedIssueCode | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology.r4b | R4B | v3-AdministrationDetectedIssueCode | AdministrationDetectedIssueCode | active | 2014-03 | uv | hl7 | tho | ||
healthdata.be.r4.cbb | R4 | AdministrationAgreementAdditionalInformation | AdministrationAgreementAdditionalInformation | draft | oid | |||||
healthdata.be.r4.cbb | R4 | AdministrationAgreementStopType | AdministrationAgreementStopType | draft | sct | |||||
healthdata.be.r4.cbb | R4 | AdministrationDevice | AdministrationDevice | draft | sct tho | |||||
ee.hl7.fhir.base.r5 | R5 | ee-administrative-gender | Administrative Gender | draft | 2023-08 | ee | hl7 | fhir | ||
ee.fhir.terminology | R5 | administrative-gender | Administrative Gender | active | 2025-06 | ee | hl7 | fhir | ||
us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.1 | Administrative Gender (HL7 V3) | active | 2019-01 | us | tho | |||
ForgePatientChart.0830 | R4 | telus-administrative-gender | TELUS ValueSet - Administrative Gender | draft | 2020-11 | hl7 | fhir | |||
fhir.kisumuhie | R4 | gender-vs | Gender | draft | 2025-06 | us | hl7 | |||
fhir.kenyaPSIG | R4 | administrative-gender-vs | Administrative Gender | active | 2025-07 | us | hl7 | fhir | ||
IdHIE.0v | R4 | value-set-administrative-gender-id-core | ValueSetAdministrativeGender (ID Core) | active | 2023-06 | hl7 | fhir | |||
MyHIE.v4-test | R4 | value-set-administrative-gender-my-core | ValueSetAdministrativeGender (MY Core) | active | 2023-01 | fhir | ||||
hl7.terminology | R5 | v3-xActEncounterReason | x_ActEncounterReason | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology.r4b | R4B | v3-xActEncounterReason | x_ActEncounterReason | active | 2014-03 | uv | hl7 | tho | ||
dk.ehealth.sundhed.fhir.ig.core | R4 | administrative-status | Administrative Status | active | 2019-02 | dk | ||||
ans.fr.terminologies | R4 | jdv-hl7-v3-AdministrativeGender-cisis | AdministrativeGender | active | 2025-06 | fr | national | tho | ||
ca.ab.fhir.psab | R4 | administrative-gender-ab | AdministrativeGender_AB | draft | 2024-06 | ca | hl7 | tho | ||
nr.gp.leumit | R4 | admission-type | Admission Type codes | draft | 2025-03 | il | ||||
ca.infoway.io.ca-csd | R4 | delivery-method | Delivery Method | draft | national | sct | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.5.3--20200901000000 | AdresSoortCodelijst | active | nl | hl7 | tho | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.5.3--20171231000000 | AdresSoortCodelijst | active | nl | fhir | ||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.645 | Pneumococcal Vaccine HD_CN_ Allergy | active | 2025-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.638 | b.well Adult Tetanus Vaccine CN | active | 2025-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.648 | bwell COVID Vaccine CN_Met | active | 2025-04 | us | hl7 | vsac | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7758 | Adverse Event Severity (TB) | active | 2017-12 | us | sct | |||
hl7.eu.fhir.idea4rc | R4 | adverse-event-type-eu-i4rc | Adverse Event Type | active | 2025-07 | eu | hl7 | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.963 | Consequence of Adverse Event | active | 2008-01 | us | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7596 | Adverse Event Severity (Malaria) | active | 2019-01 | us | sct tho oid | |||
MyHIE.v4-test | R4 | value-set-adverseevent-event-my-core | ValueSetAdverseEventEvent (MY Core) | active | 2023-03 | sct | ||||
IdHIE.0v | R4 | value-set-adverseevent-event-id-core | ValueSetAdverseEventEvent (ID Core) | draft | 2023-06 | hl7 | sct | |||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.33--20140904000000 | Advies SEO | active | nl | oid | ||||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.257--20200406134358 | Advies_1e_trimester_SEO | active | nl | oid | ||||
dk.kip.rkkp.fhir.ig.core | R4 | AfdelingDandem | Afdelinger til DANDEM | active | 2023-03 | internal | ||||
hl7.eu.fhir.idea4rc | R4 | vs-affectedOrgan-eu-i4rc | Affected Organs (surgery) | active | 2025-07 | eu | hl7 | fhir tho | ||
hl7.eu.fhir.pcsp | R4 | vs-affectedOrgan-eu-pcsp | Affected Organs (surgery) | active | 2023-01 | eu | hl7 | internal sct | ||
fhir.acme.affiliate-report | R4 | affiliate-type-vs | Affiliate Type ValueSet | draft | 2025-05 | us | hl7 | internal | ||
hl7.fhir.us.registry-protocols | R4 | YesNo | Yes or No | active | cic | 2023-11 | us | hl7 | sct tho | |
dk.kip.rkkp.fhir.ig.core | R4 | AflastendeProcedure | Aflastende procedure DCCG | active | 2022-09 | internal | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20200901000000 | AfnameprocedureCodelijst | active | nl | hl7 | sct | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.3--20171231000000 | AfwijkendAdemhalingspatroonCodelijst | active | nl | fhir sct | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3065 | Age Category (Animal) | active | 2008-01 | us | tho | |||
d4l-data4life.covid-19.r4 | R4 | age-group-de.ValueSet | Agegroup | active | ||||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3259 | Age Group (Flu) | active | 2009-01 | us | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7905 | Age units (ARLN) | active | 2019-01 | us | ucum | |||
hl7.fhir.us.davinci-pdex | R4 | ProvenanceAgentType | Provenance Agent Type | informative | fm | 2025-06 | us | hl7 | fhir tho | |
hl7.terminology | R5 | measure-aggregate-method | Measure Aggregate Method | active | cqi | 2023-02 | uv | hl7 | tho | |
hl7.terminology.r4b | R4B | measure-aggregate-method | Measure Aggregate Method | active | cqi | 2023-02 | uv | hl7 | tho | |
ans.fr.nos | R4 | JDV-J200-SousEnsembleAgregatStatutJuridique-ROR | JDV_J200-SousEnsembleAgregatStatutJuridique-ROR | active | 2024-01 | fr | national | |||
de.medizininformatikinitiative.use-case.omi | R4 | AiServiceStatusCodesVS | AiServiceStatusCodesVS | active | 2024-12 | de | ||||
kvdigital.terminsynchronisation-tvs | R4 | KBV-VS-116117-TERMINSERVICE-TVS-TSYNCH-Provenance-Activity | KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Provenance_Activity | draft | tho | |||||
dk.kip.rkkp.fhir.ig.core | R4 | AktivitetDKRR | Aktivitet (DKRR) | active | 2022-09 | internal tho | ||||
dk.kip.rkkp.fhir.ig.core | R4 | Genoplivning | Genoplivning | active | 2022-06 | internal | ||||
dk.kip.rkkp.fhir.ig.core | R4 | AktivitetSportDKRR | Aktivitet: Sport (DKRR) | active | 2022-09 | internal | ||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8054 | Alanine aminotransferase (ALT) Result (Hepatitis) | active | 2021-01 | us | tho oid | |||
hl7.eu.fhir.idea4rc | R4 | alcoholUsageStatus-athena-eu-i4rc | Alcohol Usage Status: Athena | active | 2025-07 | eu | hl7 | |||
hl7.eu.fhir.idea4rc | R4 | alcoholUsageStatus-snomed-eu-i4rc | Alcohol Usage Status: SNOMED CT | active | 2025-07 | eu | hl7 | sct | ||
ehealth4u.package | R4 | cyehr-vs-alcoholstatus | Cyprus EHR Value Set: Alcohol Status | active | sct | |||||
ehealth4u.package | R4 | cyehr-vs-alcoholtypes | Cyprus EHR Value Set: Alcohol Types | active | sct | |||||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8019 | Alcohol Use Frequency (Anthrax) | active | 2020-01 | us | sct tho oid | |||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000 | AlcoholGebruikStatusCodelijst | active | nl | hl7 | sct tho | |||
nictiz.fhir.nl.stu3.zib2015 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20150401000000 | AlcoholGebruikStatusCodelijst | retired | nl | fhir sct | ||||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20171231000000 | AlcoholGebruikStatusCodelijst | active | nl | fhir sct | ||||
healthdata.be.r4.cbb | R4 | AlcoholUseStatus | AlcoholUseStatus | draft | sct | |||||
nictiz.fhir.nl.stu3.geboortezorg | R3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.203--20141020155659 | Alcoholgebruik | active | nl | oid | ||||
nz.central.ihub.ig | R4 | nzcr-flag-alert-category-vs | NZ Central Region - Flag Alert Category Value Set | active | 2025-04 | nz | national | |||
nz.central.ihub.ig | R4 | nzcr-acombined-alert-category-vs | NZ Central Region - Combined Alert Category Value Set | active | 2025-04 | nz | national | |||
nz.central.ihub.ig | R4 | nzcr-allergy-alert-category-vs | NZ Central Region - Allergy Alert Category Value Set | active | 2025-04 | nz | national | |||
nz.central.ihub.ig | R4 | nzcr-flag-alert-code-vs | NZ Central Region - Flag Alert Code Value Set | active | 2025-04 | nz | national | tho | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000 | AlertNaamCodelijst | active | nl | hl7 | sct tho | |||
nictiz.fhir.nl.stu3.zib2015 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20150401000000 | AlertNaamCodelijst | retired | nl | fhir sct | ||||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20171231000000 | AlertNaamCodelijst | active | nl | fhir sct | ||||
healthdata.be.r4.cbb | R4 | AlertName | AlertName | draft | sct | |||||
healthdata.be.r4.cbb | R4 | AlertType | AlertType | draft | loinc | |||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20200901000000 | AlertTypeCodelijst | active | nl | hl7 | loinc | |||
nictiz.fhir.nl.stu3.zib2015 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20150401000000 | AlertTypeCodelijst | retired | nl | loinc | ||||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20171231000000 | AlertTypeCodelijst | active | nl | loinc | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.1--20200901000000 | AlertheidCodelijst | active | nl | hl7 | oid | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.12.1--20171231000000 | AlertheidCodelijst | active | nl | oid | ||||
hl7.fhir.us.registry-protocols | R4 | StressTest | Cath PCI Selected Stress Test | active | cic | 2023-11 | us | hl7 | loinc | |
fhir.cdc.opioid-cds-r4 | R4 | barbiturate-medications | Barbiturate Medications | active | 2025-02 | us | hl7 | |||
fhir.cdc.opioid-cds-r4 | R4 | buprenorphine-and-methadone-medications | Buprenorphine and Methadone medications | active | 2023-05 | us | hl7 | |||
fhir.cdc.opioid-cds-r4 | R4 | buprenorphine-medications | Buprenorphine Medications | active | 2025-02 | us | hl7 | |||
hl7.terminology | R5 | cpt-usable | AMA CPT Usable Codes | active | vocab | 2023-08 | uv | hl7 | cpt | |
hl7.terminology.r4b | R4B | cpt-usable | AMA CPT Usable Codes | active | vocab | 2023-08 | uv | hl7 | cpt | |
fhir.dicom | R4 | all | All DICOM Controlled Terminology Definitions | active | 2025-04 | us | hl7 | dcm | ||
il.core.fhir.r4 | R4 | icd9-cm-diagnoses | Icd9 Cm diagnoses | active | 2025-03 | il | national | icd | ||
hl7.v2plus | R5 | data-types | v2DataTypes | trial-use | inm | 2025-07 | hl7 | |||
hl7.fhir.us.icsr-ae-reporting | R4 | ISBTConvalescentPlasmaCodeVS | ISBT Convalescent Plasma Codes | draft | 2023-08 | us | hl7 | |||
hl7.fhir.us.icsr-ae-reporting | R4 | ISBTBloodProductCodeVS | ISBT Blood Product Codes | draft | 2023-08 | us | hl7 | |||
hl7.fhir.us.registry-protocols | R4 | SEattleAnginaQs | Seattle Angina Questions | active | cic | 2023-11 | us | hl7 | loinc | |
fhir.tx.support.r4 | R4 | covid-19-obs | COVID-19 related Observation codes | draft | 2020-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1267.13 | Screening and Assessment Survey Codes | active | 2024-10 | us | hl7 | loinc | ||
fhir.argonaut.r2 | R2 | substance-ndfrt | DAF Substance ND-FRT codes | draft | 2016-10 | us | hl7 | fhir | ||
hl7.org.nz.fhir.ig.formulary | R4B | NzmtCodes | NZMT Codes | active | 2025-07 | nz | hl7 | |||
fhir.cdc.opioid-cds-r4 | R4 | oxycodone-medications | Oxycodone Medications | active | 2025-02 | us | hl7 | |||
il.core.fhir.r4 | R4 | icd9-cm-procedures | Icd9 Cm Procedures | active | 2025-03 | il | national | icd | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6053 | Lab Test Name (Reportable Conditions) | active | 2017-01 | us | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6054 | Lab Test Result (Reportable Conditions) | active | 2016-01 | us | sct | |||
fhir.argonaut.r2 | R2 | substance-rxnorm | DAF Substance RxNorm Codes | draft | 2016-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.58 | Diabetes Medications | active | 2022-03 | us | hl7 | rx | ||
fhir.tx.support.r4 | R4 | covid-19-cond | COVID-19 related Condition codes | draft | 2020-03 | us | hl7 | sct | ||
hl7.fhir.us.registry-protocols | R4 | HemodialysisOrPeritonealDialysis | hemodialysis or peritoneal dialysis | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | CardiacArrest | Cardiac Arrest | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | CABG | Coronary artery bypass grafting | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | CerebrovascularDisease | Cerebrovascular Disease | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | PeripheralArterialOcclusiveDisease | Peripheral Arterial Occlusive Disease | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | DiabetesMellitus | Diabetes Mellitus | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | Dyslipidemia | Dyslipidemia | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | HeartFailure | Heart Failure codes from SNOMED | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | Hypertension | Hypertension | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | PercutaneousCoronaryIntervention | PCI | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | PriorCABG | Prior History of Coronary Artery Bypass Graft | active | cic | 2023-11 | us | hl7 | sct loinc | |
hl7.fhir.us.registry-protocols | R4 | HypothermiaInduced | Induced Hypothermia Codes | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | OrganDonor | SNOMED Valueset of Organ Donor codes | active | cic | 2023-11 | us | hl7 | sct | |
hl7.fhir.us.registry-protocols | R4 | AbnormalElectrocardiacAssessment | Abnormal Electrocardiac Assessment | active | cic | 2023-11 | us | hl7 | sct | |
fhir.cdc.opioid-cds-r4 | R4 | benzodiazepine-medications | Benzodiazepine medications | active | 2025-02 | us | hl7 | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.230 | All Cancer Directed therapies | active | 2024-05 | us | hl7 | rx | ||
example.fhir.ph.core | R4 | educational-attainments | Educational Attainments | draft | 2025-06 | |||||
example.fhir.ph.core | R4 | cities | Cities | draft | 2025-06 | internal | ||||
silfhirprofileig | R5 | ICD11Codes | All ICD-11 codes | active | 2025-07 | internal | ||||
silfhirprofileig | R5 | ICHICodes | All ICHI codes | active | 2025-07 | |||||
il.core.fhir.r4 | R4 | immunization-body-site | Immunization Observation Body Site list | active | 2025-03 | il | national | sct | ||
hl7.terminology | R5 | v3-IndividualCaseSafetyReportType | IndividualCaseSafetyReportType | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology.r4b | R4B | v3-IndividualCaseSafetyReportType | IndividualCaseSafetyReportType | active | 2014-03 | uv | hl7 | tho | ||
de.netzwerk-universitaetsmedizin.ebm-cpg | R5 | cochrane-pico | Cochrane PICO | draft | 2022-09 | uv | hl7 | |||
hl7.fhir.uv.saner | R4 | MeasureScoring | Measure Scoring | active | pher | 2024-05 | uv | hl7 | fhir | |
hl7.terminology | R5 | cpt-all | AMA CPT All Codes | active | vocab | 2023-08 | uv | hl7 | cpt | |
hl7.terminology.r4b | R4B | cpt-all | AMA CPT All Codes | active | vocab | 2023-08 | uv | hl7 | cpt | |
hl7.terminology | R5 | cpt-base | AMA CPT Base Codes | active | vocab | 2023-08 | uv | hl7 | cpt | |
hl7.terminology.r4b | R4B | cpt-base | AMA CPT Base Codes | active | vocab | 2023-08 | uv | hl7 | cpt |